• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOMET FRANCE S.A.R.L. REFOBACIN BONE CEMENT R 1X40 JP; BONE CEMENT, ANTIBIOTICS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOMET FRANCE S.A.R.L. REFOBACIN BONE CEMENT R 1X40 JP; BONE CEMENT, ANTIBIOTICS Back to Search Results
Catalog Number 110035373
Device Problem Unsealed Device Packaging (1444)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 08/25/2021
Event Type  malfunction  
Manufacturer Narrative
This is a combination product (b)(4).Report source, foreign - event occurred in (b)(6).The investigation is in progress.Once the investigation has been completed, a follow-up mdr will be submitted.If any further information is found which would change or alter any conclusions or information, a supplemental will be filed accordingly.
 
Event Description
It was reported that the polymer was leaking from the inner pouch because part of the inner polymer pouch was unsealed.The surgery was finished with backup product.No adverse event has been reported as the result of the malfunction.
 
Manufacturer Narrative
(b)(4).This follow-up report is being submitted to relay additional information.The investigation is in progress.Once the investigation has been completed, a follow-up mdr will be submitted.If any further information is found which would change or alter any conclusions or information, a supplemental will be filed accordingly.
 
Event Description
It was reported that the polymer was leaking from the inner pouch because part of the inner polymer pouch was unsealed.The surgery was finished with backup product.No adverse event has been reported as the result of the malfunction.
 
Manufacturer Narrative
(b)(4).This follow-up report is being submitted to relay additional information.Two pictures have been received.The first picture received shows the patient labels with the product reference and batch.The second picture shows the inner cement pouch with a corner of the sealing opened.Therefore, the reported event is confirmed.The product was returned and lab analysis was performed (see details in pce).The product analysis shows that the return product is one cement pack which comprises the outer box, the inner cement pouch, the monomer pouch and the patient labels.The inner pouch sealing is opened at both top and bottom of the pouch, allowing the cement to leak out.Therefore, the reported event is confirmed.The device manufacturing quality record indicate that the released product met all requirements to perform as intended.A sealing force test has been performed on a product received from a similar complaint ((b)(4) - same item reference) and showed that the pouch sealing force a was compliant with zimmer biomet valence specification.A complaint extract was done regarding inner cement pouch open sealing: 21 complaints (21 products), this one included, have been recorded on the brand cement pack soft pouch, all references included, to date (january 07, 2022) 3 complaints (3 products), this one included, have been recorded on refobacin bone cement r 1x40 -3, reference 110035373, batch z41dai2201.According to available data, root cause of the event was unable to be determined.However, a scar (scar-03110) has been initiated in order to deeper investigate the cause of the event with the cement pouch supplier osartis and to consider to implement actions to avoid the recurrence of this type of issue.If any further information is found which would change or alter any conclusions or information, a supplemental will be filed accordingly.Zimmer biomet will continue to monitor for trends.
 
Event Description
It was reported that the polymer was leaking from the inner pouch because part of the inner polymer pouch was unsealed.The surgery was finished with backup product.No adverse event has been reported as the result of the malfunction.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
REFOBACIN BONE CEMENT R 1X40 JP
Type of Device
BONE CEMENT, ANTIBIOTICS
Manufacturer (Section D)
BIOMET FRANCE S.A.R.L.
plateau de lautagne bp75
valence cedex 26903
FR  26903
Manufacturer (Section G)
BIOMET FRANCE S.A.R.L.
plateau de lautagne bp75
valence cedex 26903
FR   26903
Manufacturer Contact
christina arnt
56 e. bell dr.
warsaw, IN 46582
5745273773
MDR Report Key12604891
MDR Text Key277363435
Report Number3006946279-2021-00169
Device Sequence Number1
Product Code MBB
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
N/A
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional
Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date 01/10/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/11/2021
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date08/31/2022
Device Catalogue Number110035373
Device Lot NumberZ41DAI2201
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer12/23/2021
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Date Manufacturer Received01/06/2022
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured03/04/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Removal/Correction NumberN/A
Patient Sequence Number1
-
-